FDA Issues Fourth Notice of Noncompliance with ClinicalTrials.gov Requirements
25 April 2022 by CITI Program

In April of 2021, the FDA issued its first Notice of Noncompliance to a company failing to submit required summary results information to ClinicalTrials.gov. This…

What CITI Program is Reading – April 26, 2022
26 April 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

CITI Program’s April 2022 Media Playlist – Part 2
25 April 2022 by CITI Program

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…

National DNA Day – Articles and Media Playlist
25 April 2022 by CITI Program

The National Human Genome Research Institute (NHGRI) started celebrating DNA Day annually on April 25th, 2003 to provide students, educators, and others with resources to…

On Campus with CITI Program Podcast: Recap of Episodes 1-7
22 April 2022 by CITI Program

“On Campus with CITI Program” is a biweekly podcast launched in January 2022 and hosted by Darren Gaddis, Assistant Director of Content and Education at…

OLAW Requests Input on Flexibilities Available to IACUCs for Program Review
22 April 2022 by CITI Program

The NIH Office of Laboratory Animal Welfare (OLAW) is seeking public input on flexibilities that IACUCs may consider when conducting semiannual program reviews as a…

What CITI Program is Reading – April 19, 2022
19 April 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

FDA Releases Draft Guidance on the Approach for Developing a Race and Ethnicity Diversity Plan
15 April 2022 by CITI Program

The FDA has released a draft guidance document, “Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft…

FDA Publishes ICH E8(R1) Guidance
13 April 2022 by CITI Program

The FDA has published the guidance document, “E8(R1) General Considerations for Clinical Studies,” to assist those that design clinical studies by outlining the internationally accepted…

FDA Unannounced Inspections Program Resumes in India
13 April 2022 by CITI Program

The U.S. Food and Drug Administration (FDA) has resumed its unannounced foreign inspections program in India, yet it remains paused in China due to COVID-19…

What CITI Program is Reading – April 12, 2022
12 April 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

CITI Program’s April 2022 Media Playlist – Part 1
12 April 2022 by CITI Program

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…